Kolexia
Di Fiore Frederic Gastro-entérologie
Di Fiore Frederic
Gastro-entérologie
Hôpital Charles Nicolle
Rouen, France
248 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Carcinomes Adénocarcinome Métastase tumorale Tumeurs du sein Tumeurs du pancréas Tumeurs de l'oesophage Glioblastome Cellules tumorales circulantes

Collaborateurs

Voir plus
Michel Pierre
Michel Pierre
Hôpital Charles Nicolle, Rouen, France
Clatot Florian
Clatot Florian
Centre Henri-Becquerel, Rouen, France
Sefrioui David
Sefrioui David
Hôpital Charles Nicolle, Rouen, France
Sabourin Jean-Christophe
Sabourin Jean-Christophe
Hôpital Charles Nicolle, Rouen, France

Industries

Voir plus
CanceroDigest
55 collaboration(s)
Dernière en 2023
Servier
23 collaboration(s)
Dernière en 2023
Pierre Fabre
12 collaboration(s)
Dernière en 2023
Mylan Medical
9 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOUNTAINEER-03: An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
Essai Clinique (Seagen)   15 mars 2024
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Translational oncology   09 février 2024
CLIMES: Circulating Tumor DNA in Patients With Colorectal Cancer Undergoing Curative-intent Surgery for Liver Metastases: Prospective, Multicenter, GERCOR Cohort
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   02 février 2024
RePERSO: Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
Essai Clinique (CHU Rennes)   30 janvier 2024
CAPANCOVID-19: Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
Essai Clinique (CHU Reims)   23 janvier 2024
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
BMC cancer   03 novembre 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA oncology   26 octobre 2023
Quoi de neuf pour le traitement du carcinome hépatocellulaire avancé en 2022 ?
Edimark   20 octobre 2023
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
JAMA oncology   19 octobre 2023